Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03701321
Title Daratumumab, Bortezomib, and Dexamethasone With or Without Venetoclax in Treating Patients With Relapsed or Refractory Multiple Myeloma
Recruitment Withdrawn
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Indiana University/Melvin and Bren Simon Cancer Center Indianapolis Indiana 46202 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
Aurora Cancer Care-Milwaukee West Wauwatosa Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field